[Diabetes mellitus induced by drugs and chemical agents].
Hatanaka
Masayuki
M
Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University, Graduate School of Medicine.
Tanizawa
Yukio
Y
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000139:chemically induced*; D004232:Diuretics / Q000009:adverse effects*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000378:metabolism; D010419:Pentamidine / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011480:Protease Inhibitors / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents; D004232:Diuretics; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D007328:Insulin; D011480:Protease Inhibitors; D010672:Phenytoin; D010419:Pentamidine